Chronic Myeloid Leukemia in a Young Man with Unusual Presentation of Weight Loss, Bone Pain, and Abdominal Pain
Author(s) -
Niloufar Mohamadian,
Mehdi Seyedmoradi,
Babak Izadi,
Farhad Amirian,
Mazaher Ramezani
Publication year - 2022
Publication title -
basic and clinical cancer research
Language(s) - English
Resource type - Journals
eISSN - 2228-6527
pISSN - 2228-5466
DOI - 10.18502/bccr.v13i1.8833
Subject(s) - medicine , myeloproliferative neoplasm , imatinib , myeloid leukemia , abdominal pain , anorexia , weight loss , constitutional symptoms , incidence (geometry) , anemia , bone pain , presentation (obstetrics) , gastroenterology , pediatrics , surgery , bone marrow , myelofibrosis , disease , obesity , optics , physics
Chronic myeloid leukemia (CML) is a clonal myeloproliferative neoplasm and one of the main subtypes of leukemia that mainly affects adults. The incidence of CML increases slowly with age until the middle of the fourth decade, and then it rises rapidly. Anemia, splenomegaly, and constitutional symptoms are the most common signs and symptoms at presentation. Here we report a 27-year-old man with bone pain and generalized abdominal pain. He also had weight loss because of anorexia and easy satiety. The qualitative probe-based real-time PCR (qRT-PCR) result was positive for BCR-ABL1 (t9:22) P210 mutation. The patient was treated with Imatinib, the standard first-line treatment for CML, and showed clinical improvement. His pain also decreased, and he was discharged in good condition.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom